| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/04/2001 | CA2383875A1 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production |
| 01/04/2001 | CA2383865A1 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 01/04/2001 | CA2380873A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/04/2001 | CA2380871A1 Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation |
| 01/04/2001 | CA2380870A1 Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins |
| 01/04/2001 | CA2380863A1 Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport |
| 01/04/2001 | CA2377585A1 Methods for making apo-2 ligand using divalent metal ions |
| 01/04/2001 | CA2377580A1 Helical polypeptide zalpha29 |
| 01/04/2001 | CA2377531A1 Basb111 polypeptide and polynucleotide from moraxella catarrhalis |
| 01/04/2001 | CA2377484A1 Cyclic amp phosphodiesterase isoforms and methods of use |
| 01/04/2001 | CA2377229A1 Self-aligning peptides derived from human elastin and other fibrous proteins |
| 01/04/2001 | CA2370887A1 Production of the lipidated form of the peptidoglycan-associated lipoproteins of gram-negative bacteria |
| 01/04/2001 | CA2370568A1 Tankyrase2 materials and methods |
| 01/04/2001 | CA2370517A1 Stabilized viral envelope proteins and uses thereof |
| 01/04/2001 | CA2339404A1 Synthetic peptide immunogens and antibodies thereto |
| 01/03/2001 | EP1065271A1 Phagemide for screening antibodies |
| 01/03/2001 | EP1064952A2 Methods and compositions for the suppression of neu mediated transformations |
| 01/03/2001 | EP1064551A1 Development of human monoclonal antibodies and uses thereof |
| 01/03/2001 | EP1064550A1 AN EQUINE $i(NEOSPORA) ISOLATE AND ITS USES |
| 01/03/2001 | EP1064388A1 Human casb12 polypeptide, a serine protease |
| 01/03/2001 | EP1064382A2 Polypeptides homologous to vegf and bmp1 |
| 01/03/2001 | EP1064381A1 Cardiostatin polypeptides and polynucleotides |
| 01/03/2001 | EP1064380A1 EXPRESSION OF THE $i(INSL4) GENE IN HUMAN EMBRYONIC BONE TISSUES AND APPLICATIONS |
| 01/03/2001 | EP1064372A2 Compounds and methods for therapy and diagnosis of lung cancer |
| 01/03/2001 | EP1064370A2 Protein phosphatase-related molecules |
| 01/03/2001 | EP1064369A2 Nucleic acid binding proteins |
| 01/03/2001 | EP1064368A1 Suppressors of cytokine signalling |
| 01/03/2001 | EP1064367A2 Production of biofilaments in transgenic animals |
| 01/03/2001 | EP1064366A1 $i(STAPHYLOCOCCUS AUREUS) GENES AND POLYPEPTIDES |
| 01/03/2001 | EP1064364A1 The cytokine family member 2-21 |
| 01/03/2001 | EP1064360A2 Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics |
| 01/03/2001 | EP1064359A2 Phenol oxidizing enzyme enzymes |
| 01/03/2001 | EP1064309A2 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of hcv viral antigen in host tissue |
| 01/03/2001 | EP1064306A1 $i(NEPHRIN) GENE AND PROTEIN |
| 01/03/2001 | EP1064303A1 Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen |
| 01/03/2001 | EP1064301A1 Bacterial yael family members as targets for antimicrobial drug design |
| 01/03/2001 | EP1064299A1 Cyclohexapeptide wf14573 or its salt, production thereof and use thereof |
| 01/03/2001 | EP1064297A1 95 human secreted proteins |
| 01/03/2001 | EP1064295A1 METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME-18p RELATED DISORDERS |
| 01/03/2001 | EP1064019A1 Chemically modified mutant enzymes and methods for producing them and screening them |
| 01/03/2001 | EP1064007A1 nrdG |
| 01/03/2001 | EP1064006A1 Treatment of ulcerative colitis with tropomyosin isoforms and monoclonal antibodies to tropomyosin isoforms |
| 01/03/2001 | EP0828759B1 Process of high purity albumin production |
| 01/03/2001 | EP0816506B1 System for the expression of heterologous antigens as fusion proteins |
| 01/03/2001 | CN1278736A Hmanized antibodies to human gp39, compositions containing and therapeutic use thereof |
| 01/03/2001 | CN1278557A Human protein kinase inhibitor gamma and its code sequence, preparation and use |
| 01/03/2001 | CN1278556A Human montage factor II and its code sequence, preparation and use |
| 01/03/2001 | CN1278555A New human stroma cell protein and its code sequence |
| 01/03/2001 | CN1060216C Improved methods for the preparation of endotoxinbinding proteins |
| 01/03/2001 | CN1060212C Dictyestelium dipeptidlaminopeptidase, its separation method and use thereof |
| 01/02/2001 | US6169174 Dna coding for a protein of defined amino acid sequence which controls fiber formation; for improvements in textile, paper and food industries |
| 01/02/2001 | US6169172 Chimeric protein of a protein of interest which is extended at amino-terminal with second defined amino acid sequence; for recombinant production in eukaryotic cells |
| 01/02/2001 | US6169167 Antibodies to ligands for HEK4 receptors |
| 01/02/2001 | US6169070 Mer receptor activation by gas6 |
| 01/02/2001 | US6169068 Treating lung disease or disorder by inhalating a protein |
| 01/02/2001 | US6168933 Nucleotide sequences coding a transport protein; for the classification, diagnosis, prevention, and treatment of defects in cell proliferation, lipid metabolism and transport |
| 01/02/2001 | US6168931 Enhanced in vitro synthesis of biological macromolecules using a novel ATP regeneration system |
| 01/02/2001 | US6168927 Expression of G protein coupled receptors in yeast |
| 01/02/2001 | US6168926 Screening for modulators of preferential enzyme activity; incubating cells with modulators and detecting expression of reporter molecules, amplification of expression indicates an inhibitor, decreased expression indicates an activator |
| 01/02/2001 | US6168920 Extracellular adhesive proteins |
| 01/02/2001 | US6168797 FabF |
| 01/02/2001 | US6168791 Antibodies that bind immunomodulators |
| 01/02/2001 | US6168790 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria |
| 01/02/2001 | US6168783 Antagonists of interleukin-15 |
| 01/02/2001 | CA2113203C Human calcium channel compositions and methods |
| 01/02/2001 | CA2035899C Chimeric anti-cea antibody |
| 01/02/2001 | CA2034979C Antibiotic, deoxymulundocandin, a process for its production and its useas medicament |
| 01/02/2001 | CA2025070C Recombinant aprotinin variants genetically engineered process for the microbial preparation of homgeneously processed aprotinin variants and the therapeutic use thereof |
| 01/02/2001 | CA2019218C Magnetic protein conjugates, a process for the preparation thereof and the use thereof |
| 01/02/2001 | CA2007336C Diagnostic test using chimeric antibodies |
| 01/02/2001 | CA1341160C Bovine granulocyte-macrophage colony stimulating factor |
| 12/28/2000 | WO2000078978A1 Pichia methanolica glyceraldehyde 3-phosphate dehydrogenase 1 promoter and terminator |
| 12/28/2000 | WO2000078975A2 Rice sucrose synthase promoter |
| 12/28/2000 | WO2000078972A2 Regulation with binding cassette transporter protein abc1 |
| 12/28/2000 | WO2000078971A2 Atp binding cassette transporter protein abc1 popypeptides |
| 12/28/2000 | WO2000078954A2 Human transcriptional regulator proteins |
| 12/28/2000 | WO2000078953A2 Human transport proteins |
| 12/28/2000 | WO2000078952A2 Human rna metabolism proteins (rmep) |
| 12/28/2000 | WO2000078947A1 Head trauma induced cytoplasmatic calcium binding protein |
| 12/28/2000 | WO2000078925A1 Rapid growing microorganisms for biotechnology applications |
| 12/28/2000 | WO2000078922A2 Acid-inducible promoters for gene expression |
| 12/28/2000 | WO2000078807A1 Purified antigen for alzheimer's disease, and methods of obtaining and using same |
| 12/28/2000 | WO2000078806A1 Mage-a1 peptides presented by hla class ii molecules |
| 12/28/2000 | WO2000078805A1 Peptide having preptin functionality |
| 12/28/2000 | WO2000078787A1 ISOLATED GENES FROM VIRULENT GROUP B $i(STREPTOCOCCUS AGALACTIAE) |
| 12/28/2000 | WO2000078444A2 Method and device for carrying out biochemical reactions with a high throughput |
| 12/28/2000 | WO2000078344A1 Prion protein peptides and uses thereof |
| 12/28/2000 | WO2000078337A1 Compositions containing soluble forms of hla-g for treating inflammatory skin pathologies |
| 12/28/2000 | WO2000078266A2 Interferon tau mutants and methods for making them |
| 12/28/2000 | WO2000058460A3 Casb619 involved in colon cancers |
| 12/28/2000 | WO2000049162A3 Compositions and methods for non-targeted activation of endogenous genes |
| 12/28/2000 | WO2000046344A3 Non-stochastic generation of genetic vaccines and enzymes |
| 12/28/2000 | WO2000046343A3 Screening assay for antagonists of fgfr-mediated malignant cell transformation and tumor formation |
| 12/28/2000 | WO2000043495A3 33 human secreted proteins |
| 12/28/2000 | WO2000037640A3 Compositions and methods for the treatment of tumor |
| 12/28/2000 | WO2000034474A3 Growth factor homolog zvegf3 |
| 12/28/2000 | WO2000032776A3 Secreted amd transmembrane polypeptides and nucleic acids encoding the same |
| 12/28/2000 | WO2000017369B1 Alzheimer's disease secretase |
| 12/28/2000 | CA2397494A1 Pichia methanolica glyceraldehyde-3-phosphate dehydrogenase 1 promoter and terminator |
| 12/28/2000 | CA2386393A1 Purified antigen for alzheimer's disease, and methods of obtaining and using same |